Optimal primary end point in Phase II trials of immune checkpoint inhibitors for advanced solid cancers: an evolving issue.Giandomenico Roviello,Daniele Generali,Anna IanzaIMMUNOTHERAPY（2019）引用 0|浏览8暂无评分关键词end points,immunotherapy,PD-1,PD-L1,Phase IIAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
